Long-term levetiracetam treatment of epilepsy patients: Clinical audit

Epilepsy Research

Volumn 72, Issue 2-3, 2006, Pages 111-119

  Kuba, R ^a   Novotna I ^a   Brazdil M ^a   Kocvarova J ^a   Tyrlikova I ^a   Mastik J ^a   Rektor, I ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Efficacy; Epilepsy; Levetiracetam; Long term therapy; Tolerability

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM;

ADOLESCENT; ADULT; AGED; AGGRESSION; ANTICONVULSANT THERAPY; ARTICLE; ASTHENIA; ATAXIA; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DISEASE EXACERBATION; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECZEMA; FEMALE; GRAND MAL SEIZURE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOOD CHANGE; PRIORITY JOURNAL; SIDE EFFECT; SIMPLE PARTIAL SEIZURE; SKIN MANIFESTATION; SOMNOLENCE; TREATMENT OUTCOME; VERTIGO; WEIGHT GAIN;

ANTICONVULSANTS; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; EPILEPSY; HUMANS; KAPLAN-MEIERS ESTIMATE; PIRACETAM; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 33845330210     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2006.07.005     Document Type: Article

References (10)

1. Abou-Khalil B., and Lazenby B. Long-term experience with levetiracetam. Epileptic Disord. 53 Suppl. 1 (2003) S33-S37
2. Ben-Menachem E., Edrich P., Van Vleymen B., Sander J.W.A.S., and Schmidt B. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Epilepsy Res. 53 (2003) 57-64
3. Ben-Menachem E., and Gilland E. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy. Seizure 12 (2003) 131-135
4. Betts T., Yarrow H., Greenhill L., and Barrett M. Clinical experience of marketed levetiracetam in an epilepsy clinic-a one year follow up study. Seizure 12 (2003) 136-140
5. Depondt C., Yuen A.W.C., Bell G.S., Mitchel T., Koepp M.J., Duncan J.S., and Sander J.W. The long term retention of levetiracetam in a large cohort of patients with epilepsy. J. Neurol. Neurosurg. Psychiatry 77 (2006) 101-103
6. French J., and Arrigo C. Rapid onset of action of levetiracetam in refractory epilepsy patients. Epilepsia 46 (2005) 4-326
7. Kaplan E.L. Non-parametric estimation from incomplete observations. Am. Stat. Assoc. J. 53 (1958) 457-481
8. Mohanraj R., Parker P.G., Stephen L.J., and Brodie M.J. Levetiracetam in refractory epilepsy: a prospective obsevational study. Seizure 14 (2005) 23-27
9. Motamedi M., Nuyen D.K., Zaatreh M., Singh S.P., Westerveld M., Thompson J.L., Mattson R., Blumenfeld H., Novotny E., and Spencer S.S. Levetiracetam efficacy in refractory partial-onset seizures especially after failed epilepsy surgery. Epilepsia 44 (2003) 211-214
10. Steinhoff B., Backer M., Frenck W., Bilic S., Ernst J., Kraus U., Martin P., Schneble H., and Wiemer-Kruel A. Levetiracetam add-on treatment: one-year retention in an epilepsy centre. Epilepsia 43 Suppl. 8 (2002) S116